Boston An independent LDT provider

Investigator-initiated studies (IIS)

Immunovia, Inc. is dedicated to supporting independent clinical research that is consistent with our commitment to the early detection of pancreatic cancer and is conducted by qualified investigators. Support of research may include funding or testing services.

To submit a research proposal, please submit a Letter of Intent along with a study protocol for consideration. Immunovia, Inc. will review all research proposals within 60 days of receipt, and all proposals will be reviewed based on merit by a review committee. Support is subject to resource availability and requires an approved study proposal, a full study protocol, and full execution of a research support agreement by both the investigator and Immunovia, Inc.

Please submit your Letter of Intent and the study protocol to